期刊文献+

N-乙酰半胱氨酸对PC12细胞的保护作用研究 被引量:1

Protective effect of N-acetylcysteine against rotenone-induced apoptosis in PC12 cells
原文传递
导出
摘要 目的探讨N-乙酰半胱氨酸(NAC)对PC12细胞的保护作用及其机制。方法采用神经毒素1μmol/L鱼藤酮处理PC12细胞24h,并在处理前30min加入500μmol/L的NAC进行干预,流式细胞术检测PC12细胞的凋亡率和活性氧水平,比色法检测还原型谷胱甘肽(GSH)水平。结果PC12细胞经1μmol/L鱼藤酮处理24h后,细胞凋亡率达41.9%,细胞内活性氧水平较对照组显著提高,而GSH水平显著下降(P<0.05);NAC干预后,能够明显抑制鱼藤酮的细胞毒性作用,与鱼藤酮组相比,细胞凋亡率和活性氧水平显著降低,GSH含量明显增加(P<0.05)。结论在帕金森病(PD)的细胞模型中,通过NAC的干预,能够明显保护PC12细胞,其保护机制与抗氧化能力有关。 Objective To investigate the protective effect of N- acetylcysteine(NAC) on PC12 cells in rotenone-induced cell injury. Methods PC12 cells were treated with 1μmol/L of rotenone for 24 h. Additionally,N- acetylcysteine(500 μmol/L) was added 30rain before rotenone treatment. Apoptosis and reactive oxygen species (ROS) were both determined with flow cytometry(FCM). Glutathione assay kit was used to assess the level of intracellular glutathione. Results After rotenone treatment,the apoptosis rate of PC12 cells was up to 41.9%. Rotenone treatment also enhanced the production of ROS and decreased the level of GSH(P〈0. 05). Pretreatment with NAC partially inhibited the toxic effect of rotenone, suggested by decreased apoptosis rate and ROS formation and elevated GSH levels when comparing with rotenone group. Conclusions In this cell model of Parkinson's disease, NAC protected PC12 cells against the toxicity of rotenone and the mechanism was associated with its antioxidant ability.
作者 胡丹 张兆辉
出处 《卒中与神经疾病》 2009年第6期328-330,共3页 Stroke and Nervous Diseases
关键词 帕金森病 鱼藤酮 N-乙酰半胱氨酸 Parkinson's disease Rotenone N- acetylcysteine
  • 相关文献

参考文献8

  • 1Fukui H, Moraes CT. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? Trends Neurosci, 2008,31 (5) : 251 256.
  • 2Zhou C, Huang Y, Przedborski S. Oxidative Stress in Parkinson's Disease A Mechanism of Pathogenic and Therapeutic Significance. Ann N Y Acad Sci, 2008,1147: 93-104.
  • 3Dekhuijzen PN. Antioxidant propertoes of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur Respir J,2004,23(4):629-636.
  • 4Molina-Jimenez MF,Sache~Reus MI, Benedi J. Effect of fraxetin and myricetin on rotenone-induced cytotoxicity in SH-SY5Y cells= comparison with N acetylcysteine. Eur J Pharmacol,2003, 472(1-2):81-87.
  • 5Moldeus P,Cotgreave IA,Berggren M. Lung protection by a thiol-containing antioxidant: N-aeetylcysteine. Respiration,1986,50 (Suppl 1 ) : 31-42.
  • 6Atkuri KR, Mantovani J J, Herzenberg LA, et al. N-Acetylcysteine-a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol, 2007,7 (4) : 355-359.
  • 7Bharat S,Cochran BC, Hsu M, et al. Pre-treatment with R lipoic acid alleviates the effects of GSH depletion in PC12 cells: impli cations for Parkinson's disease therapy. Neurotoxicology, 2002,23 (4 5) : 479 486.
  • 8Chinta SJ, Anderson JK. Redox imbalance in Parkinson's disease. Biochim Biophys Acta,2008,1780(11 ) : 1362-1367.

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部